Pulmonary artery pseudoaneurysm secondary to COVID-19 treated with endovascular embolisation.

经血管内栓塞治疗的 COVID - 19 继发肺动脉假性动脉瘤。

• 发表时间: 2021
• 来源期刊: Eur J Radiol Open
• DOI: 10.1016/j.ejro.2021.100346
• PMID: 33898655
• 文章类型: Case Reports
• 作者列表: Khurram R,Karia P,Naidu V,Quddus A,Woo WL,Davies N

关键词: COVID-19; CT, computed tomography; CTPA, computed tomography pulmonary angiogram; Embolisation; Haemoptysis; LMWH, low molecular weight heparin; PAP, pulmonary artery pseudoaneurysm; Pseudoaneurysm; Pulmonary artery

Abstract

Pulmonary artery pseudoaneurysms are uncommon and can cause severe, life-threatening haemoptysis. We present a case of a 74-year-old gentleman who was being treated for COVID-19 pneumonitis and a concomitant segmental pulmonary artery thrombus with conventional treatment and anticoagulation. The patient developed significant haemoptysis during admission. A repeat computed tomography pulmonary angiogram revealed an 8 mm left upper lobe pulmonary artery pseudoaneurysm. Anticoagulation was withheld and the pseudoaneurysm was successfully treated with endovascular embolisation with an Amplatzer® IV plug, leading to resolution of the haemoptysis. To our knowledge this is the first case of a pulmonary artery pseudoaneurysm secondary to COVID-19.

摘要

肺动脉假性动脉瘤并不常见，可导致严重的，危及生命的咯血.我们介绍了一名74岁的绅士，他正在接受COVID-19肺炎和伴随的节段性肺动脉血栓的常规治疗和抗凝治疗。患者在入院期间出现明显咯血。重复的计算机断层扫描肺血管造影显示左上叶8毫米的肺动脉假性动脉瘤。停止抗凝治疗，假性动脉瘤通过Amplatzer®IV栓塞血管内栓塞治疗成功。导致咯血的消退。据我们所知，这是第一例继发于COVID-19的肺动脉假性动脉瘤。